Bank of New York Mellon’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $674K | Buy |
125,716
+6,696
| +6% | +$35.9K | ﹤0.01% | 3326 |
|
|
2025
Q1 | $636K | Buy |
119,020
+193
| +0.2% | +$1.03K | ﹤0.01% | 3314 |
|
|
2024
Q4 | $1.06M | Buy |
118,827
+892
| +0.8% | +$7.97K | ﹤0.01% | 3109 |
|
|
2024
Q3 | $1.3M | Sell |
117,935
-21,136
| -15% | -$233K | ﹤0.01% | 2987 |
|
|
2024
Q2 | $1.27M | Buy |
139,071
+8,965
| +7% | +$81.6K | ﹤0.01% | 3056 |
|
|
2024
Q1 | $1.83M | Buy |
130,106
+37,853
| +41% | +$533K | ﹤0.01% | 2807 |
|
|
2023
Q4 | $709K | Buy |
92,253
+22,500
| +32% | +$173K | ﹤0.01% | 3361 |
|
|
2023
Q3 | $520K | Buy |
69,753
+330
| +0.5% | +$2.46K | ﹤0.01% | 3520 |
|
|
2023
Q2 | $578K | Buy |
+69,423
| New | +$578K | ﹤0.01% | 3503 |
|
|
2021
Q3 | – | Sell |
-2,549
| Closed | -$32K | – | 4514 |
|
|
2021
Q2 | $32K | Sell |
2,549
-7,972
| -76% | -$100K | ﹤0.01% | 4361 |
|
|
2021
Q1 | $183K | Buy |
10,521
+1,749
| +20% | +$30.4K | ﹤0.01% | 4075 |
|
|
2020
Q4 | $113K | Sell |
8,772
-362
| -4% | -$4.66K | ﹤0.01% | 4058 |
|
|
2020
Q3 | $339K | Buy |
9,134
+1,954
| +27% | +$72.5K | ﹤0.01% | 3668 |
|
|
2020
Q2 | $276K | Buy |
+7,180
| New | +$276K | ﹤0.01% | 3710 |
|
|
2018
Q2 | – | Sell |
-234
| Closed | -$25K | – | 4202 |
|
|
2018
Q1 | $25K | Buy |
+234
| New | +$25K | ﹤0.01% | 4241 |
|
|
2016
Q2 | – | Sell |
-206
| Closed | -$63K | – | 4316 |
|
|
2016
Q1 | $63K | Buy |
206
+10
| +5% | +$3.06K | ﹤0.01% | 4046 |
|
|
2015
Q4 | $93K | Buy |
196
+12
| +7% | +$5.69K | ﹤0.01% | 4052 |
|
|
2015
Q3 | $89K | Buy |
+184
| New | +$89K | ﹤0.01% | 4086 |
|